Jafron Biomedical Co.,Ltd. (SHE:300529)
20.69
+0.52 (2.58%)
Jan 23, 2026, 3:04 PM CST
-23.74% (1Y)
| Market Cap | 16.02B |
| Revenue (ttm) | 2.04B |
| Net Income (ttm) | 481.79M |
| Shares Out | 774.36M |
| EPS (ttm) | 0.63 |
| PE Ratio | 32.87 |
| Forward PE | 21.28 |
| Dividend | 0.80 (3.87%) |
| Ex-Dividend Date | May 26, 2025 |
| Volume | 6,400,644 |
| Average Volume | 5,534,374 |
| Open | 20.51 |
| Previous Close | 20.17 |
| Day's Range | 20.20 - 20.70 |
| 52-Week Range | 19.19 - 27.73 |
| Beta | 0.48 |
| RSI | 58.29 |
| Earnings Date | Apr 28, 2026 |